ReP USP - Resultado da busca

Artigo de periodico
Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro (2021)
Silva, Rai Campos ; Freitas, Humberto F.; Campos, Joaquín M.; Kimani, Njogu M.; Silva, Carlos Henrique Tomich de Paula da ; Borges, Rosivaldo S.; Pita, Samuel S. R.; Santos, Cleydson B. R.
Source: International Journal of Molecular Sciences. Unidades: FCFRP, FFCLRP
Subjects: COVID-19, PRODUTOS NATURAIS, SAÚDE PÚBLICA, FARMACOCINÉTICA, ANÁLISE TOXICOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Rai Campos et al. Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro. International Journal of Molecular Sciences, v. 22, n. 21, p. 1-24, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms222111739. Acesso em: 09 nov. 2024.
APA
Silva, R. C., Freitas, H. F., Campos, J. M., Kimani, N. M., Silva, C. H. T. de P. da, Borges, R. S., et al. (2021). Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro. International Journal of Molecular Sciences, 22( 21), 1-24. doi:10.3390/ijms222111739
NLM
Silva RC, Freitas HF, Campos JM, Kimani NM, Silva CHT de P da, Borges RS, Pita SSR, Santos CBR. Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 21): 1-24.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/ijms222111739
Vancouver
Silva RC, Freitas HF, Campos JM, Kimani NM, Silva CHT de P da, Borges RS, Pita SSR, Santos CBR. Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 21): 1-24.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/ijms222111739
Artigo de periodico
Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: a bioinformatics approach (2020)
Leão, Rozires P.; Cruz, Josiane V.; Costa, Glauber V. da; Cruz, Jorddy N.; Ferreira, Elenilze F. B.; Silva, Rai Campos ; Lima, Lúcio R. de; Borges, Rosivaldo S.; Santos, Gabriela B. dos; Santos, Cleydson B. R.
Source: Pharmaceuticals. Unidade: FFCLRP
Subjects: ANTI-INFLAMATÓRIOS, BIOINFORMÁTICA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEÃO, Rozires P. et al. Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: a bioinformatics approach. Pharmaceuticals, v. 13, n. 9, p. 1-26, 2020Tradução . . Disponível em: https://doi.org/10.3390/ph13090209. Acesso em: 09 nov. 2024.
APA
Leão, R. P., Cruz, J. V., Costa, G. V. da, Cruz, J. N., Ferreira, E. F. B., Silva, R. C., et al. (2020). Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: a bioinformatics approach. Pharmaceuticals, 13( 9), 1-26. doi:10.3390/ph13090209
NLM
Leão RP, Cruz JV, Costa GV da, Cruz JN, Ferreira EFB, Silva RC, Lima LR de, Borges RS, Santos GB dos, Santos CBR. Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: a bioinformatics approach [Internet]. Pharmaceuticals. 2020 ; 13( 9): 1-26.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/ph13090209
Vancouver
Leão RP, Cruz JV, Costa GV da, Cruz JN, Ferreira EFB, Silva RC, Lima LR de, Borges RS, Santos GB dos, Santos CBR. Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: a bioinformatics approach [Internet]. Pharmaceuticals. 2020 ; 13( 9): 1-26.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/ph13090209
Artigo de periodico
Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease (2020)
Souza, Lucilene R.; Picanço, Leide C. S.; Brito, Maiara F. B.; Almeida, Marcos R. S.; Marino, Bianca L. B.; Sousa, Kessia P. A.; Ferreira, Jaderson V.; Santos, Cleydson B. R.; Silva, Guilherme Martins da ; Silva, Carlos Henrique Tomich de Paula da ; Taft, Carlton A.; Melim, Lorane Izabel da Silva Hage
Source: Central Nervous System Agents in Medicinal Chemistry. Unidades: FCFRP, FFCLRP
Subjects: FARMACOCINÉTICA, DOENÇA DE PARKINSON, PLANEJAMENTO DE FÁRMACOS, FÁRMACOS (SISTEMA NERVOSO CENTRAL), RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Lucilene R. et al. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease. Central Nervous System Agents in Medicinal Chemistry, v. 20, n. 2, p. 128-143, 2020Tradução . . Disponível em: https://doi.org/10.2174/1871524920666200217110211. Acesso em: 09 nov. 2024.
APA
Souza, L. R., Picanço, L. C. S., Brito, M. F. B., Almeida, M. R. S., Marino, B. L. B., Sousa, K. P. A., et al. (2020). Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease. Central Nervous System Agents in Medicinal Chemistry, 20( 2), 128-143. doi:10.2174/1871524920666200217110211
NLM
Souza LR, Picanço LCS, Brito MFB, Almeida MRS, Marino BLB, Sousa KPA, Ferreira JV, Santos CBR, Silva GM da, Silva CHT de P da, Taft CA, Melim LI da SH. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2020 ; 20( 2): 128-143.[citado 2024 nov. 09 ] Available from: https://doi.org/10.2174/1871524920666200217110211
Vancouver
Souza LR, Picanço LCS, Brito MFB, Almeida MRS, Marino BLB, Sousa KPA, Ferreira JV, Santos CBR, Silva GM da, Silva CHT de P da, Taft CA, Melim LI da SH. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2020 ; 20( 2): 128-143.[citado 2024 nov. 09 ] Available from: https://doi.org/10.2174/1871524920666200217110211
Artigo de periodico
Computational design of new protein kinase 2 inhibitors for the treatment of inflammatory diseases using QSAR, pharmacophore-structure-based virtual screening, and molecular dynamics (2018)
Cruz, Josiane Viana; Serafim, Rodolfo Bortolozo; Silva, Gabriel Monteiro da; Giuliatti, Silvana; Rosa, Joaquín M. C.; Araújo Neto, Moysés F.; Leite, Franco Henrique Andrade; Taft, Carlton A.; Silva, Carlos Henrique Tomich de Paula da; Santos, Cleydson B. R.
Source: Journal of Molecular Modeling. Unidades: FMRP, FCFRP
Subjects: ANTI-INFLAMATÓRIOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZ, Josiane Viana et al. Computational design of new protein kinase 2 inhibitors for the treatment of inflammatory diseases using QSAR, pharmacophore-structure-based virtual screening, and molecular dynamics. Journal of Molecular Modeling, v. 24, n. 9, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00894-018-3756-y. Acesso em: 09 nov. 2024.
APA
Cruz, J. V., Serafim, R. B., Silva, G. M. da, Giuliatti, S., Rosa, J. M. C., Araújo Neto, M. F., et al. (2018). Computational design of new protein kinase 2 inhibitors for the treatment of inflammatory diseases using QSAR, pharmacophore-structure-based virtual screening, and molecular dynamics. Journal of Molecular Modeling, 24( 9). doi:10.1007/s00894-018-3756-y
NLM
Cruz JV, Serafim RB, Silva GM da, Giuliatti S, Rosa JMC, Araújo Neto MF, Leite FHA, Taft CA, Silva CHT de P da, Santos CBR. Computational design of new protein kinase 2 inhibitors for the treatment of inflammatory diseases using QSAR, pharmacophore-structure-based virtual screening, and molecular dynamics [Internet]. Journal of Molecular Modeling. 2018 ; 24( 9):[citado 2024 nov. 09 ] Available from: https://doi.org/10.1007/s00894-018-3756-y
Vancouver
Cruz JV, Serafim RB, Silva GM da, Giuliatti S, Rosa JMC, Araújo Neto MF, Leite FHA, Taft CA, Silva CHT de P da, Santos CBR. Computational design of new protein kinase 2 inhibitors for the treatment of inflammatory diseases using QSAR, pharmacophore-structure-based virtual screening, and molecular dynamics [Internet]. Journal of Molecular Modeling. 2018 ; 24( 9):[citado 2024 nov. 09 ] Available from: https://doi.org/10.1007/s00894-018-3756-y

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation